Anti-BORCS8-MEF2B monoclonal antibody

Pre-made anti-BORCS8-MEF2B monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to BORCS8-MEF2B/BORCS8-MEF2B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2375-Ab-1/ GM-Tg-hg-IP2375-Ab-2Anti-Human BORCS8-MEF2B monoclonal antibodyHuman
GM-Tg-rg-IP2375-Ab-1/ GM-Tg-rg-IP2375-Ab-2Anti-Rat BORCS8-MEF2B monoclonal antibodyRat
GM-Tg-mg-IP2375-Ab-1/ GM-Tg-mg-IP2375-Ab-2Anti-Mouse BORCS8-MEF2B monoclonal antibodyMouse
GM-Tg-cynog-IP2375-Ab-1/ GM-Tg-cynog-IP2375-Ab-2Anti-Cynomolgus/ Rhesus macaque BORCS8-MEF2B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2375-Ab-1/ GM-Tg-felg-IP2375-Ab-2Anti-Feline BORCS8-MEF2B monoclonal antibodyFeline
GM-Tg-cang-IP2375-Ab-1/ GM-Tg-cang-IP2375-Ab-2Anti-Canine BORCS8-MEF2B monoclonal antibodyCanine
GM-Tg-bovg-IP2375-Ab-1/ GM-Tg-bovg-IP2375-Ab-2Anti-Bovine BORCS8-MEF2B monoclonal antibodyBovine
GM-Tg-equg-IP2375-Ab-1/ GM-Tg-equg-IP2375-Ab-2Anti-Equine BORCS8-MEF2B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2375-Ab-1/ GM-Tg-hg-IP2375-Ab-2; GM-Tg-rg-IP2375-Ab-1/ GM-Tg-rg-IP2375-Ab-2;
GM-Tg-mg-IP2375-Ab-1/ GM-Tg-mg-IP2375-Ab-2; GM-Tg-cynog-IP2375-Ab-1/ GM-Tg-cynog-IP2375-Ab-2;
GM-Tg-felg-IP2375-Ab-1/ GM-Tg-felg-IP2375-Ab-2; GM-Tg-cang-IP2375-Ab-1/ GM-Tg-cang-IP2375-Ab-2;
GM-Tg-bovg-IP2375-Ab-1/ GM-Tg-bovg-IP2375-Ab-2; GM-Tg-equg-IP2375-Ab-1/ GM-Tg-equg-IP2375-Ab-2
Products NameAnti-BORCS8-MEF2B monoclonal antibody
Formatmab
Target NameBORCS8-MEF2B
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-BORCS8-MEF2B monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2375-Ag-1Recombinant multi-species BORCS8-MEF2B/ LOC729991-MEF2B/ MEF2B protein


    Target information

    Target IDGM-IP2375
    Target NameBORCS8-MEF2B
    Gene ID4207
    Gene Symbol and SynonymsBORCS8-MEF2B,LOC729991-MEF2B,MEF2B,MEF2BNB-MEF2B,RSRFR2
    Uniprot AccessionN/A
    Uniprot Entry Name
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000213999
    Target ClassificationN/A

    The target: BORCS8-MEF2B, gene name: BORCS8-MEF2B, also named as LOC729991-MEF2B, MEF2B, MEF2BNB-MEF2B. This gene represents numerous read-through transcripts that span GeneID:729991 and 100271849. Many read-through transcripts are predicted to be nonsense-mediated decay (NMD) candidates, and are thought to be non-coding. Some transcripts are predicted to be capable of translation reinitiation at a downstream AUG, resulting in expression of at least one isoform of myocyte enhancer factor 2B (MEF2B) from this read-through locus. At least one additional MEF2B variant and isoform can be expressed from a downstream promoter, and is annotated on GeneID:100271849. [provided by RefSeq, Oct 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.